8-K: FIGS Inc. Announces Q3 2024 Results, Minority Investment in AI Education Platform OOG
Quarterly Report
FIGS Inc. reported a slight decrease in revenue for Q3 2024 and announced a $25 million minority investment in OOG, an AI-powered education platform for healthcare professionals.
Summary
- FIGS Inc. released its third quarter 2024 financial results, showing a 1.5% year-over-year decrease in net revenues to $140.2 million.
- The company's gross margin decreased by 1.3% to 67.1%, primarily due to higher discounted sales and product mix shifts.
- Operating expenses increased by 17.4% year-over-year to $102.7 million, driven by higher marketing and fulfillment center transition costs.
- Net loss for the quarter was $1.7 million, a decrease of $7.8 million compared to the same period last year.
- Adjusted EBITDA was $4.8 million, a decrease of $19.6 million year-over-year, with an adjusted EBITDA margin of 3.4%.
- Active customers increased by 3.8% year-over-year to 2.7 million, while net revenue per active customer decreased by 3.3% to $205.
- Average order value (AOV) decreased by 5.3% year-over-year to $108.
- FIGS completed the transition to a new, state-of-the-art fulfillment center and launched an Olympics campaign with the Team USA Medical Team.
- The company made a $25 million minority investment in OOG, Inc., an AI-powered education platform for healthcare professionals.
- FIGS updated its full-year 2024 outlook, now expecting net revenue growth to be down 1% to flat and adjusted EBITDA margin to be around 8%.
Sentiment
Score: 4
Explanation: The document presents mixed results with a significant decrease in profitability and revenue, offset by some positive developments like the investment in OOG and the completion of the fulfillment center. The overall tone is cautious due to the financial challenges.
Positives
- Active customers increased by 3.8% year-over-year, indicating continued growth in the customer base.
- The company completed the transition to a new, state-of-the-art fulfillment center.
- FIGS made a strategic minority investment in OOG, Inc., which is expected to provide benefits in marketing, community engagement, data, and AI.
- The company's brand interest and engagement remain high, with newness and innovation resonating with customers.
- FIGS is focused on maintaining a strong balance sheet and cash flow to support future investments.
Negatives
- Net revenues decreased by 1.5% year-over-year, indicating a slowdown in sales growth.
- Gross margin decreased by 1.3%, primarily due to higher discounts and product mix shifts.
- Operating expenses increased significantly by 17.4%, impacting profitability.
- The company reported a net loss of $1.7 million for the quarter, a significant decrease compared to the net income of $6.1 million in the same period last year.
- Adjusted EBITDA decreased substantially by $19.6 million year-over-year.
- Net revenue per active customer and average order value both decreased, indicating lower spending per customer.
- The company experienced challenges related to footwear inventory, promotional timing, and fulfillment center ramp-up costs.
Risks
- The company's ability to maintain historical growth rates is uncertain.
- Maintaining profitability is a challenge, as evidenced by the net loss in Q3 2024.
- The company faces risks related to brand reputation, customer retention, and marketing effectiveness.
- Competition in the healthcare apparel market is intense.
- The company is exposed to risks associated with international expansion, supply chain disruptions, and fluctuating raw material costs.
- Cybersecurity risks and the failure to protect intellectual property are potential threats.
- The company's reliance on a limited number of third-party suppliers poses a risk.
- Macroeconomic trends and changes in consumer behavior could impact demand for the company's products.
Future Outlook
For the full year 2024, FIGS expects net revenue growth to be down 1% to flat compared to 2023, and adjusted EBITDA margin to be approximately 8%.
Management Comments
- Trina Spear, Chief Executive Officer and Co-Founder, stated that the third quarter included key investments to support and scale FIGS, including the Olympics campaign and the fulfillment center transition.
- Ms. Spear noted that financial performance showed positive signs with high brand interest and engagement, but also experienced challenges with footwear inventory, promotional timing, and fulfillment center ramp-up costs.
- Ms. Spear expressed excitement about investing in and collaborating with OOG, believing it will transform the healthcare education industry and expand how FIGS serves its customers.
Industry Context
The investment in OOG, an AI-powered education platform, indicates a move by FIGS to expand beyond apparel and into the broader healthcare professional ecosystem. This aligns with a trend of companies seeking to offer more comprehensive solutions to their target markets. The results also highlight the challenges of balancing growth with profitability in a competitive market.
Comparison to Industry Standards
- FIGS' revenue decline of 1.5% contrasts with some apparel brands that have seen growth, but is not uncommon in the current economic climate.
- The decrease in gross margin to 67.1% is a concern, as many premium apparel brands aim for higher margins, often above 70%. For example, Lululemon consistently reports gross margins in the high 50s.
- The significant increase in operating expenses to 73.2% of net revenues is high compared to established apparel companies, which typically manage operating expenses more efficiently. For example, Nike's operating expenses are typically around 30% of revenue.
- The adjusted EBITDA margin of 3.4% is significantly lower than many established apparel brands, which often have margins in the double digits. For example, Under Armour's adjusted EBITDA margin is typically around 10%.
- The decrease in average order value (AOV) to $108 is a negative trend, as premium brands often strive to maintain or increase AOV. For example, Lululemon's AOV is typically above $120.
- The investment in OOG is a unique move, as most apparel companies do not typically invest in education platforms. This could be a strategic differentiator for FIGS if successful.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Special Committee Formation | A Special Committee comprised of independent directors was formed to evaluate and negotiate the OOG investment due to related party transactions. | November 4, 2024 | Ensures independent oversight and mitigates potential conflicts of interest. |
Related Party Transactions
- Heather Hasson, Executive Chair of FIGS, is the founder and CEO of OOG, creating a related party transaction that required a special committee review.
Stakeholder Impact
- Shareholders may be concerned about the decrease in revenue and profitability, as well as the reduced full-year outlook.
- Employees may be affected by the company's efforts to address challenges and improve performance.
- Customers may benefit from the company's investment in OOG, which aims to improve the healthcare professional experience.
- Suppliers may be impacted by the company's efforts to manage inventory and costs.
- Creditors may be concerned about the company's financial performance and ability to meet its obligations.
Next Steps
- FIGS will work with OOG to develop a commercial agreement that will provide benefits in marketing, community engagement, data, and AI.
- The company will continue to address challenges related to footwear inventory, promotional timing, and fulfillment center ramp-up costs.
- FIGS will host a conference call and webcast to discuss the financial results and outlook.
Key Dates
| Date | Description |
|---|---|
| November 4, 2024 | FIGS entered into a Series A Preferred Stock Purchase Agreement with OOG, Inc. |
| November 7, 2024 | FIGS announced its Q3 2024 financial results and the investment in OOG, Inc. |
| November 14, 2024 | The recording of the conference call discussing the financial results will be available until this date. |
Keywords
healthcare apparel, direct-to-consumer, financial results, minority investment, AI platform, OOG, EBITDA, net revenue, gross margin, fulfillment center, active customers, average order value
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.